Activity of gatifloxacin compared to those of five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infections

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 6, 1999, Pages 1475-1479

  Goldstein, Ellie J C ^a,b,c   Citron, Diane M ^a   Merriam, C Vreni ^a   Tyrrell, Kerin ^a   Warren, Yumi ^a  

^a Santa Monica UCLA Medical Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; GATIFLOXACIN; GREPAFLOXACIN; LEVOFLOXACIN; QUINOLONE DERIVATIVE; SPARFLOXACIN; TROVAFLOXACIN;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DILUTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SOFT TISSUE; WOUND INFECTION;

EID: 0033043409     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.6.1475     Document Type: Article

References (27)

1. Alexander, C. J., D. M. Citron, S. H. Gerardo, M. C. Claros, D. Talan, and E. J. C. Goldstein. 1997. Characterization of saccharolytic Bacteroides and Prevotella isolates from infected dog and cat bite wounds in humans. J. Clin. Microbiol. 35:406-411.
2. Anonymous. 30 May 1997. Dog bites have increased 37%, p. A-3. The Outlook, Santa Monica, Calif.
3. Brook, I. 1987. Microbiology of human and animal bite wounds in children. Pediatr. Infect. Dis. J. 6:29-32.
4. Citron, D. M., M. C. Claros, S. H. Gerardo, F. Abrahamlan, D. A. Talan, and E. J. C. Goldstein. 1996. Frequency of Porphyromonas species isolated from infected dog and cat bite wounds in humans and their characterization by biochemical tests and AP-PCR fingerprinting. Clin. Infect. Dis. 23(Suppl. 1):78-82.
5. Ednie, L. M., M. R. Jacobs, and P. C. Appelbaum. 1998. Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms. Antimicrob. Agents Chemother. 42:2459-2462.
6. Erwin, M. E., R. N. Jones, M. S. Barrett, M. A. Pfaller, C. L. Hayward, and G. V. Doern. 1998. Comparative antimicrobial activity of gatifloxacin, a new 8-methoxyfluoroquinolone, tested against Campylobacter jejuni and anaerobic bacteria, abstr. E-191, p. 224. In Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
7. Goldstein, E. J. C. 1991. Bite wounds and infection. Clin. Infect. Dis. 14: 633-640.
8. Goldstein, E. J. C., D. M. Citron, B. Wield, V. Blachman, V. L. Sutter, T. A. Miller, and S. M. Finegold. 1978. Bacteriology of human and animal bite wounds. J. Clin. Microbiol. 8:667-672.
9. Goldstein, E. J. C., and D. M. Citron. 1993. Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents. Antimicrobial Agents & Chemotherapy 37:1150-1153.
10. Goldstein, E. J. C., D. M. Citron, M. Hudspeth, S. H. Gerardo, and C. V. Merriam. 1998. Trovafloxacin compared to levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite wound pathogens. J. Antimicrob. Chemother. 41:391-396.
11. Holdeman, L. V., and W. E. C. Moore. 1977. Anaerobic laboratory manual, 4th ed. Virginia Polytechnic Institute and State University, Blacksburg.
12. Holst, E., J. Rollof, L. Larsson, and J. P. Nielsen. 1992. Characterization and distribution of Pasteurella species recovered from infected humans. J. Clin. Microbiol. 30:2984-2987.
13. Hosaka, M., T. Yasue, H. Fukuda, H. Tomizawa, H. Aoyama, and K. Hirai. 1992. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro8-methoxy quinoline. Antimicrob. Agents Chemother. 36:2108-2117.
14. Hosaka, M., S. Kinoshita, A. Toyama, M. Otsuki, and T. Nishino. 1995. Antibacterial properties of AM-1155, a new 8-methoxy quinolone. J. Antimicrob. Chemother. 36:293-301.
15. Levin, J. M., and D. A. Talan. 1990. Erythromycin failure with subsequent Pasteurella multocida meningitis and septic arthritis in a cat bite victim. Ann. Emerg. Med. 19:1458-1461.
16. Murray, P. R., E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.). 1995. Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
17. Mutters, R., P. Ihm, S. Pohl, W. Frederiksen, and W. Mannheim. 1985. Reclassification of the genus Pasteurella Trevisan 1887 on the basis of deoxyribonucleic acid homology, with proposals for the new species Pasteurella dagmatis, Pasteurella canis, Pasteurella stomalis, Pasteurella anatis, and Pasteurella langaa. Int. J. Syst. Bacteriol. 35:309-322.
18. National Committee for Clinical Laboratory Standards. 1998. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 4th ed. Approved standard. NCCLS publication no. M11-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
19. National Committee for Clinical Laboratory Standards. 1998. Method for dilution antimicrobial susceptibility testing for bacteria that grow aerobically, 4th ed. Approved standard. NCCLS publication no. M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
20. Orton, D. W. 1984. Pasteurella multocida: bilateral septic knee joint prosthesis from a distant cat bite. Ann. Emerg. Med. 13:1065-1067.
21. Sachs, J. J., M. Kresnow, and B. Houston. 1996. Dog bites: how big a problem? Injury Prev. 2:52-54.
22. Schaumann, R., M. C. Claros, B. Pless, and A. C. Rodloff. 1998. In vitro activity of gatifloxacin against anaerobic bacteria compared with other quinolones and non-quinolone antimicrobials, abstr. E-177, p. 220. In Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
23. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1994. Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes. Antimicrob. Agents Chemother. 38:2471-2476.
24. Summanen, P., E. J. Baron, D. M. Citron, C. A. Strong, H. M. Wexler, and S. M. Finegold. 1993. Wadsworth anaerobic bacteriology manual, 5th ed. Star Publishing Co., Belmont, Calif.
25. Talan, D. A., D. M. Citron, F. A. Abrahamian, G. J. Moran, E. J. C. Goldstein, and the Emergency Medicine Animal Bite Infection Study Group. 1999. The bacteriology and management of dog and cat bite wound infections presenting to emergency departments. N. Engl. J. Med. 340:85-92.
26. Wakabayashi, E., and S. Mitsuhashi. 1994. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone. Antimicrob. Agents Chemother. 38:594-601.
27. Wexler, H. M., E. Molitoris, D. Molitoris, and S. M. Finegold. 1996. In vitro activity of trovafloxacin against 557 strains of anaerobic bacteria. Antimicrob. Agents Chemother. 40:2232-2235.